Jupiter Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History
Bought
Maintained
Sold
Other funds holding INDV
OCM
TSC
Jupiter Asset Management's INDV Position: Q2 2026 in Review
Jupiter Asset Management opened a new position in Indivior Pharmaceuticals (INDV) in Q2 2026: 197,149 shares worth $8.09M. The stake represents 0.04% of the portfolio and ranks #319 among its holdings. This is a return to the name: Jupiter Asset Management previously reported a position in INDV as recently as Q4 2023.
Jupiter Asset Management first reported a position in INDV in Q2 2023 and has held it in 4 quarters since. The position peaked at $15.3M in Q2 2023. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.
- Jupiter Asset Management held 197,149 shares of Indivior Pharmaceuticals worth $8.09M as of Q2 2026.
- Indivior Pharmaceuticals was a new Jupiter Asset Management position in Q2 2026.
- Indivior Pharmaceuticals made up 0.04% of Jupiter Asset Management's portfolio in Q2 2026, its #319 holding.
- Jupiter Asset Management first reported a position in Indivior Pharmaceuticals in Q2 2023 and has held it in 4 quarters since.
- Jupiter Asset Management's Indivior Pharmaceuticals position peaked at $15.3M in Q2 2023.
- 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.
Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.